HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3.

Abstract
We investigated immunologic function in six cases with hypophosphatemic vitamin D-resistant rickets (VDRR) before and after treatment with 1 alpha-hydroxycholecalciferol (1 alpha(OH) vitamin D3). All cases suffered frequent episodes of infection, which tended to be more severe in the older patients. OKT9-, OKT10-, and OKM1-positive cells and adenosine deaminase (ADA) were significantly increased, whereas numbers and activity of natural killer (NK) cells were lower than normal before treatment. After administration of 1 alpha(OH) vitamin D3, however, the susceptibility to infection apparently decreased, and NK cell number and activity increased in all patients. ADA was also significantly decreased and remained in the normal range after treatment. These results suggest that vitamin D plays a role in the impaired immunoregulatory functions of NK cells in VDRR. Furthermore, ADA may be one parameter reflecting this immunologic impairment.
AuthorsI Kitajima, I Maruyama, H Matsubara, M Osame, A Igata
JournalClinical immunology and immunopathology (Clin Immunol Immunopathol) Vol. 53 Issue 1 Pg. 24-31 (Oct 1989) ISSN: 0090-1229 [Print] United States
PMID2548783 (Publication Type: Journal Article)
Chemical References
  • Hydroxycholecalciferols
  • Adenosine Deaminase
  • alfacalcidol
Topics
  • Adenosine Deaminase (analysis)
  • Adolescent
  • Adult
  • Aged
  • Child
  • Disease Susceptibility
  • Female
  • Humans
  • Hydroxycholecalciferols (pharmacology, therapeutic use)
  • Hypophosphatemia, Familial (complications, drug therapy, genetics, immunology)
  • Immunity, Cellular (drug effects)
  • Immunologic Deficiency Syndromes (drug therapy, etiology)
  • Killer Cells, Natural (drug effects, immunology)
  • Leukopenia (drug therapy, etiology)
  • Lymphocytes (classification)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: